I would assume because the FDA would only accept blinded or double-blinded in certain scenarios (probably at the pointy Ph3 end)
Ann: Q3 2023 quarterly activity and cash flow report, page-16
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.06 |
Change
-0.480(3.83%) |
Mkt cap ! $1.507B | |||
| Open | High | Low | Value | Volume |
| $12.45 | $12.45 | $11.88 | $1.758M | 146.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 45 | $12.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.06 | 120 | 1 |
View Market Depth
| Last trade - 10.55am 23/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |